Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Diabetes Care|March 1, 2003
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria studyKasper Rossing, Per K Christensen, Steen Andersen, et al.
Kidney International. Supplement|March 9, 2005
Renoprotection with and without blood pressure reductionGozewijn Dirk Laverman, Steen Andersen, Peter Rossing, et al.
Diabetes Care|September 5, 2020
Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 DiabetesAjenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, et al.
Danish Medical Journal|September 5, 2013
Mechanism of injury and microbiological flora of the geographical location are essential for the prognosis in soldiers with serious warfare injuriesMik Wetterslev, Katrine Rose-Larsen, Jacob Hansen-Schwartz, et al.
Diabetes Care|April 30, 2003
Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.
Kidney International|June 26, 2002
Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.
American Heart Journal|March 5, 2004
Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudyJacob E Møller, Ulf Dahlström, Ole Gøtzsche, et al.
Diabetes Care|December 24, 2005
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathyTri Q Nguyen, Lise Tarnow, Steen Andersen, et al.
Seminars in Nephrology|March 16, 2004
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end pointsHans-Henrik Parving, Steen Andersen, Peter Jacobsen, et al.
Kidney International|May 11, 2005
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathySteen Andersen, Frans A van Nieuwenhoven, Lise Tarnow, et al.
Pageof 6